Facial Function Reanimation by Electrical Pacing in Unilateral Facial Paralysis.

Facial Nerve Palsy Clinical Trial

Official title:

Mimetic Interfaces - Toispuoleisen Kasvohermohalvauksen Kojeellinen Kuntoutus Terveen Puolen Lihasaktiviteettiohjauksella. Stimulaattorin Prototyypin Testaus terveillä koehenkilöillä ja Kasvohermohalvauspotilailla.

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03496025
• Other study ID #: R15067
• Status: Active, not recruiting
• Phase: Phase 1
• Start date: August 1, 2015
• Est. completion date: May 31, 2021

Study information

• Verified date: September 2019
• Source: Tampere University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Purpose of the trial is to study the activations of paralyzed facial muscles in a unilateral facial nerve palsy with a multi-channel electrical stimulator. The principle of the device is to measure muscle activity of the healthy side of the face by surface electromyography (EMG) and to use this information to stimulate the corresponding muscles of the paralyzed side. The ultimate goal is to develop a prosthetic device for persons with a facial nerve palsy. The trial consists of several different studies. The studies' aims are 1. To study activations of paralyzed facial muscles by the electrical stimulation. 2. To study different stimulation pulse waveforms, frequencies, and electrode placement and their effect on the muscle activations and the tolerability of the stimulation. 3. To study whether a symmetrical movement on the paralyzed side can be achieved with electrical stimulation when compared to the movements of the healthy side. 4. To study tolerability of stimulation-elicited eye blink when watching a film and the effect of the stimulation-induced blink on the eye symptoms, the visual acuity, and the effects of the stimulation on the lacrimal fluid. 5. To develop a method for facial pacing, i.e. measuring the muscle activations on the healthy side of the face and to use this information to stimulate and activate the healthy side of the face. Forty subjects with a chronic facial nerve palsy are recruited to the studies. Each subject can participate in one or several studies. Another forty subjects with an acute facial nerve palsy are recruited to the study on the tolerability and effect on the eye symptoms. Additionally, altogether ninety healthy volunteers are recruited to the studies in order to gather preliminary information on the tolerability and the effects of the stimulations.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 77
• Est. completion date: May 31, 2021
• Est. primary completion date: October 31, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• a unilateral peripheral facial nerve palsy (patients)
• willingness to participate (patients, healthy volunteers)

Exclusion Criteria:

• malignant diseases (a previously treated cancer is not an exclusion criterion)
• unstable cardiovascular disease
• severe immune deficiency
• other severe neurological diseases (causing cognitive or physical impairment)
• diabetic neuropathy

Related Conditions & MeSH terms

• Bell Palsy
• Facial Nerve Diseases
• Facial Nerve Palsy
• Facial Paralysis
• Facies

Intervention

Device:
• Electrical muscle stimulation
The intervention consists of activating paralyzed facial muscles with electrical stimulation.

Locations

Country	Name	City	State
Finland	Tampere University Hospital	Tampere

Sponsors (4)

Lead Sponsor	Collaborator
Tampere University Hospital	Helsinki University Central Hospital, Tampere University, Tampere University of Technology

Country where clinical trial is conducted

Finland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Amplitudee of the movement elicited by electrical stimulation	The offline video analysis is done to determine the current threshold at which a movement of the target muscle is produced. Possible activations of the other muscles alongside the target muscle are also observed. The amplitude of the movement is analyzed offline from a video recording either visually by the investigators, or measured with a digital ruler. With visual evaluation, the outcome is measured on a rough level, i.e. whether the stimulated movement was larger in amplitude compared to the voluntary movement. With a digital ruler, the results a presented numerically (millimeters). The stimulated activation is compared to the voluntary activation of the muscle. Further, in some sub-studies, the facial activations are evaluated with the Facial Action Coding System.	Immediate
Secondary	Subjective ratings related to the tolerability of stimulations	The participants evaluate the experienced discomfort and painfulness of the stimulation with a numeric rating scale (NRS).	Immediate
Secondary	Subjective ratings related to acceptability of the stimulated movement	The participants evaluate the naturalness and symmetry and their satisfaction with the stimulation elicited movement with an NRS.	Immediate
Secondary	Visual acuity	In substudies concerning the elicitation of eye blink, The visual acuity is measured for both eyes separately with a LogMAR chart before and after the stimulation session.	Immediate
Secondary	Changes in lacrimal fluid	In substudies concerning the elicitation of eye blink, a lacrimal fluid sample is collected before and after the stimulation session to investigate the possible effects of the stimulation in its constitution.	Immediate